Purchase Order SPE2DP26P0393

<p>The Defense Logistics Agency's Medical Supply Chain issued a purchase order to Fenwal, Inc. on February 5, 2026, for blood packs with anticoagulant, valued at $2,334.42. No set-aside was used. Performance takes place at Fenwal's facility in Lake Zurich, Illinois. The order closes February 10, 2026.</p>

Fenwal, Inc., a Lake Zurich, Illinois-based blood technology manufacturer and subsidiary of Fresenius Kabi, has been awarded a firm fixed-price purchase order valued at $1,214.16 by the Defense Logistics Agency Medical Supply Chain for Anticoagulant Citra products. The contract, awarded January 27, 2026, carries an ultimate completion date of February 11, 2026, and was issued without a set-aside designation, reflecting Fenwal's specialized capabilities in transfusion medicine. As the prime...

This federal contract award, valued at $1,818.60, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the supply of 8510735219 ANTICOAGULANT CITRA and does not have a set-aside designation. Fenwal, Inc. is an established vendor with the U.S. federal government, providing a wide range of medical supplies and equipment to support critical healthcare and research initiatives. This...

The Defense Logistics Agency Medical Supply Chain awarded a $3,581.75 firm fixed-price purchase order to Fenwal, Inc. for washing solution on January 27, 2026, with an ultimate completion date of May 27, 2026. This contract carries no set-aside designation, reflecting Fenwal's specialized capabilities as the sole source provider for this critical blood banking consumable. Fenwal, a subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, is a global blood technology company that...

This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and supplies. The contract is for the delivery of blood packs with anticoagulant, with a ceiling value of $3,303.84 and a completion date of August 18, 2025. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007, and has consistently secured...

This federal contract award, valued at $1,839.04, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of blood packs with anticoagulant (8510030842) and has a completion date of August 14, 2023. Fenwal, a registered federal vendor since 2007, has a strong track record of supporting the U.S. government's healthcare and research initiatives by providing a diverse array...

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....

The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order valued at $3,967.24 to Fenwal, Inc. for a hand blood sealer on November 7, 2025, with an ultimate completion date of December 1, 2025. The contract, issued without set-aside designation, reflects Fenwal's established position as a specialized supplier of blood collection, separation, storage, and transfusion products to federal health agencies. Fenwal, a subsidiary of Fresenius Kabi headquartered...

This is a firm fixed price (FFP) purchase order awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical products and equipment. The $220,180.33 contract has a base period plus three one-year option periods to provide the following deliveries annually: 60 cases of 12% sodium chloride solution, 1 case of Sepacell pre-storage leukocyte reduction products, 88 cases of Amicus apheresis kits, and 24 cases of Intersol solution. The requirement had...

The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on March 25, 2025, for the supply of intravenous fluids for blood bank operations. Valued at $16,608.88 with an ultimate completion date of September 1, 2025, this contract represents a non-set-aside award supporting critical blood banking capabilities. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, will perform this work at Agana...